Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics
May 26, 2026
May 26, 2026
Some Canadians will be able to buy brand-name GLP-1 drug Ozempic at a reduced price, Danish drugmaker Novo Nordisk said in a statement Tuesday.
The move comes as two generic versions of Ozempic and Wegovy, both produced by Novo Nordisk, have started arriving in Canadian pharmacies, which means patients who use the drug to treat diabetes or for weight loss may have more options for a fraction of the cost.
Earlier this month, Health Canada approved both Dr. Reddy’s and Apotex’s generic semaglutide — the active ingredient in brand-name Ozempic that is prescribed for diabetes and Wegovy, which is the same drug but under a different name and at a higher dose when prescribed for weight loss.
The drugs, known as GLP-1 agonists, work by triggering insulin release, blocking sugar production in your liver and making you feel full for longer by slowing the flow of food through the digestive system.
Read more: https://globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.